A little-known biotech firm focused on Traditional Chinese Medicine has surged over 64,000%, catapulting its valuation to nearly $10 billion. Is this a biotech breakthrough, a speculative frenzy, or something in between?
Join Dan Koh and Ryan Huang as they dissect the rise of Regencell Bioscience Holdings Limited — a company with just 12 employees, no FDA-approved products, and a CEO earning $1 a year.

Ask Kelly: Kelly Latimer Gets in the Hot Seat
14:42

Ask Colette: Colette Wong Answers YOUR Questions!
12:32

Singapore Unfiltered: What Does A Healthy Employer-Helper Relationship Look Like?
20:00